Scpharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy SCPH

*Your capital is at risk

$5.67

+0 (+0%)

At Close: Jan 06, 2026

scPharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -95.05. In total, the insiders bought 480K and sold 5.06M SCPH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-95.05
● Buy	480K shares
● Sell	5.06M shares
16% Buy Activity Moderate Negative Correlation
Sell Signal High Confidence Oct 07, 2025 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -95.05. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming sell-side pressure (16% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 07, 2025 Sell	Common Stock U-Tender	Schaeffer Leonard D Director	Director	43 104 Value: $0
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Schaeffer Leonard D Director	Director	30 000 Value: $115.5K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Schaeffer Leonard D Director	Director	19 750 Value: $81.2K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Schaeffer Leonard D Director	Director	16 300 Value: $73.8K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Veitinger Klaus R Dr Director	Director	30 000 Value: $115.5K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Veitinger Klaus R Dr Director	Director	19 750 Value: $81.2K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Veitinger Klaus R Dr Director	Director	16 300 Value: $73.8K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Veitinger Klaus R Dr Director	Director	6 124 Value: $20.6K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Abraham William Tober Director	Director	30 000 Value: $115.5K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Abraham William Tober Director	Director	19 750 Value: $81.2K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Abraham William Tober Director	Director	16 300 Value: $73.8K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Baylor-henry Minnie Director	Director	30 000 Value: $115.5K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Baylor-henry Minnie Director	Director	19 750 Value: $81.2K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Baylor-henry Minnie Director	Director	16 300 Value: $73.8K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Baylor-henry Minnie Director	Director	6 124 Value: $20.6K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Baylor-henry Minnie Director	Director	12 248 Value: $58.8K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Hudson Frederick M. Director	Director	30 000 Value: $115.5K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Hudson Frederick M. Director	Director	19 750 Value: $81.2K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Hudson Frederick M. Director	Director	16 300 Value: $73.8K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Hudson Frederick M. Director	Director	6 124 Value: $20.6K
Oct 07, 2025 Sell	Common Stock U-Tender	Nokes Rachael CFO And Treasurer	C-Suite Officer	30 386 Value: $0
Oct 07, 2025 Sell	Common Stock D-Return	Nokes Rachael CFO And Treasurer	C-Suite Officer	125 675 Value: $672.4K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Nokes Rachael CFO And Treasurer	C-Suite Officer	132 670 Value: $443.1K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Nokes Rachael CFO And Treasurer	C-Suite Officer	54 700 Value: $235.8K
Oct 07, 2025 Sell	Stock Option (Right to Buy) D-Return	Nokes Rachael CFO And Treasurer	C-Suite Officer	6 426 Value: $24.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SCPHARMACEUTICALS INC.

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by